What happened
FDA inspected Fresenius USA Manufacturing’s Ogden, Utah drug facility from March 2-6, 2026, and cited significant CGMP violations involving complaint investigations, CAPA, process controls, and visual inspection of sterile injectable products. For Delflex Peritoneal Dialysis Solution, an August 2025 investigation covered 35 complaints involving approximately 156 leaking bags from multiple batches and attributed holes to printing. FDA stated that the firm assigned the lowest severity despite its matrix identifying peritonitis as a potential harm at the highest severity, did not recall then, and inadequately investigated risk and implemented CAPA. After inspection, reexamination found perforations without substantial fluid in the overwrap; the firm reassessed risk and recalled affected lots on April 6, 2026 for lack of assurance of sterility. FDA found the response still lacked sufficient CAPA to improve leak detection. FDA also found personnel qualification for visual particulate inspection inadequate because the kit was not adequately representative and records lacked sufficient detail, and said the response did not demonstrate reliable detection at an appropriate level.
Why it matters
From a GMP and manufacturing perspective, recurring bag leaks may indicate weaknesses in container integrity, printing controls, defect detection, process capability, equipment qualification, and ongoing process monitoring. FDA linked delayed containment to potential exposure of dialysis patients to non-sterile product and noted that dextrose could support microbial growth. Inadequate complaint investigations, risk assessment, CAPA, and quality unit oversight may impede timely identification and control of recurring defects. Weak visual inspector qualification may also reduce confidence that visible particulates are reliably detected in sterile injectable products.
Key topics: Inadequate investigation and CAPA for recurring leaking dialysis solution bags, Underestimation of peritonitis and sterility risks from primary container perforations, Inadequate qualification of personnel performing visual particulate inspection